Effects of physical exercise on cognitive alterations and oxidative stress in an APP/PSN1 transgenic model of Alzheimer's disease;Efecto del ejercicio fi;sico sobre las alteraciones cognitivas y el estre;s oxidativo en un modelo transge;nico APP/PSN1 para la enfermedad de Alzheimer

Revista Espanola de Geriatria y Gerontologia

Volumn 47, Issue 5, 2012, Pages 198-204

  Pareja Galeano, Helios ^a   Brioche, Thomas ^b   Sanchís Gomar, Fabia n ^a   Escriva, Consuelo ^a   Dromant, Mar ^a   Go mez Cabrera, Mari Carmen ^a   Viña, Jose ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UFR APS   (France)

Author keywords

Antioxidant; Anxiety; Memory; Training; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN CORTEX; COGNITION; CONTROLLED STUDY; DISEASE MODEL; ENZYME INDUCTION; EXERCISE; EXPLORATORY BEHAVIOR; GRIP STRENGTH; LIPID PEROXIDATION; MEMORY; MOUSE; NONHUMAN; OXIDATIVE STRESS; TRANSGENIC ANIMAL; TREADMILL EXERCISE; VENOUS OXYGEN TENSION; ANIMAL; COGNITIVE DEFECT; GENETICS; METABOLISM; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; PHYSICAL CONDITIONING, ANIMAL; PRESENILIN-1;

EID: 84866596476     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/j.regg.2012.05.004     Document Type: Article

References (44)

1. Jicha G.A., Carr S.A. Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. J Alzheimers Dis 2010, 19:253-2272.
2. Pope S.K., Shue V.M., Beck C. Will a healthy lifestyle help prevent Alzheimer's disease?. Annu Rev Public Health 2003, 24:111-132.
3. Radak Z., Hart N., Sarga L., Koltai E., Atalay M., Ohno H., et al. Exercise plays a preventive role against Alzheimer's disease. J Alzheimers Dis 2010, 20:777-783.
4. Lazarov O., Mattson M.P., Peterson D.A., Pimplikar S.W., van Praag H. When neurogenesis encounters aging and disease. Trends Neurosci 2010, 33:569-579.
5. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689-695.
6. Shimohama S., Tanino H., Kawakami N., Okamura N., Kodama H., Yamaguchi T., et al. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 2000, 273:5-9.
7. Qin B., Cartier L., Dubois-Dauphin M., Li B., Serrander L., Krause K.H. A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiol Aging 2006, 27:1577-1587.
8. Holscher C. Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homeostasis. Neurobiol Dis 1998, 5:129-141.
9. Cardoso S.M., Santos S., Swerdlow R.H., Oliveira C.R. Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J 2001, 15:1439-1441.
10. Lautenschlager N.T., Cox K.L., Flicker L., Foster J.K., van Bockxmeer F.M., Xiao J., et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008, 300:1027-1037.
11. Rockenstein E., Crews L., Masliah E. Transgenic animal models of neurodegenerative diseases and their application to treatment development. Adv Drug Deliv Rev 2007, 59:1093-1102.
12. Yan P., Bero A.W., Cirrito J.R., Xiao Q., Hu X., Wang Y., et al. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J Neurosci 2009, 29:10706-10714.
13. Liu H.L., Zhao G., Cai K., Zhao H.H., Shi L.D. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation. Behav Brain Res 2011, 218:308-314.
14. Ke H.C., Huang H.J., Liang K.C., Hsieh-Li H.M. Selective improvement of cognitive function in adult and aged APP/PS1 transgenic mice by continuous non-shock treadmill exercise. Brain Res 2011, 1403:1-11.
15. Catlow B.J., Rowe A.R., Clearwater C.R., Mamcarz M., Arendash G.W., Sa;nchez-Ramos J. Effects of environmental enrichment and physical activity on neurogenesis in transgenic PS1/APP mice. Brain Res 2009, 1256:173-179.
16. Lazarov O., Robinson J., Tang Y.P., Hairston I.S., Korade-Mirnics Z., Lee V.M., et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005, 120:701-713.
17. Davidson S.R., Burnett M., Hoffman-Goetz L. Training effects in mice after long-term voluntary exercise. Med Sci Sports Exerc 2006, 38:250-255.
18. Go;mez-Cabrera M.C., Dome;nech E., Romagnoli M., Arduini A., Borra;s C., Pallardo F.V., et al. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr 2008, 87:142-149.
19. Davies K.J., Packer L., Brooks G.A. Exercise bioenergetics following sprint training. Arch Biochem Biophys 1982, 215:260-265.
20. Brooks G.A., White T.P. Determination of metabolic and heart rate responses of rats to treadmill exercise. J Appl Physiol 1978, 45:1009-1015.
21. Ennaceur A., Meliani K. A new one-trial test for neurobiological studies of memory in rats III. Spatial vs. non-spatial working memory. Behav Brain Res 1992, 51:83-92.
22. Hammond R.S., Tull L.E., Stackman R.W. On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 2004, 82:26-34.
23. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. Behavioral data. Behav Brain Res 1988, 31:47-59.
24. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
25. Wong S.H., Knight J.A., Hopfer S.M., Zaharia O., Leach C.N., Sunderman F.W. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987, 33:214-220.
26. Asensi M., Sastre J., Pallardo F.V., Garci;a de la Asuncio;n J., Estrela J.M., Vina J. A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples. Anal Biochem 1994, 217:323-328.
27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
28. Myers J., Prakash M., Froelicher V., Do D., Partington S., Atwood J.E. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002, 346:793-801.
29. Lalonde R., Kim H.D., Fukuchi K. Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/DeltaE9 mice. Neurosci Lett 2004, 369:156-161.
30. Buchman A.S., Schneider J.A., Leurgans S., Bennett D.A. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology 2008, 71:499-504.
31. Dere E., Huston J.P., de Souza Silva M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 2007, 31:673-704.
32. Ashe K.H. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn Mem 2001, 8:301-308.
33. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 1999, 29:177-185.
34. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000, 408:982-985.
35. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 2002, 22:1858-1867.
36. Lalonde R., Kim H.D., Maxwell J.A., Fukuchi K. Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett 2005, 390:87-92.
37. Hall C.S. Emotional behavior in the rat: I. Defecation and urination as measures of individual differences in emotionality. J Comp Psychol 1934, 18:385-403.
38. Garci;a-Mesa Y., Lo;pez-Ramos J.C., Gime;nez-Llort L., Revilla S., Guerra R., Gruart A., et al. Physical exercise protects against Alzheimer's disease in 3×Tg-AD mice. J Alzheimers Dis 2011, 24:421-454.
39. Richter H., Ambree O., Lewejohann L., Herring A., Keyvani K., Paulus W., et al. Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom?. Behav Brain Res 2008, 190:74-84.
40. Vina J., Lloret A., Valles S.L., Borras C., Badi;a M.C., Pallardo F.V., et al. Mitochondrial oxidant signalling in Alzheimer's disease. J Alzheimers Dis 2007, 11:175-181.
41. Go;mez-Cabrera M.C., Dome;nech E., Vina J. Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. Free Radic Biol Med 2008, 44:126-131.
42. Radak Z., Kumagai S., Taylor A.W., Naito H., Goto S. Effects of exercise on brain function: role of free radicals. Appl Physiol Nutr Metab 2007, 32:942-946.
43. Martins I., Galluzzi L., Kroemer G. Hormesis, cell death and aging. Aging (Albany NY) 2011, 3:821-828.
44. Radak Z., Chung H.Y., Koltai E., Taylor A.W., Goto S. Exercise, oxidative stress and hormesis. Ageing Res Rev 2008, 7:34-42.